Skylight Health Group Inc.

Thank you everyone for standing by. This is the conference operator. We would like to welcome you to the Skylight Health fourth quarter and full year 2021 financial results conference call. The results are for the period ending December 31st, 2021. As a reminder, all participants are in listen only mode. After today's speakers conclude the presentation portion of the call, should time permit, they'll move on to a question and answer period. If you wish to ask a question, you may queue at any time by pressing star then 1 on your telephone keypad. You will hear a tone acknowledging your request. To withdraw your question, please press star then 2. Should you need assistance during a conference call, you may signal an operator by pressing star and 0. As always, I would like to remind you that listeners are cautioned that today's call and the responses to any questions may contain forward-looking statements. including certain statements which concern long-term earnings objectives. These should be considered in conjunction with the company's cautionary statements contained in the Skylight Health earnings release and in the company's MD&A and other filings. Forward-looking statements are subject to risks and uncertainties and assumptions. Accordingly, actual performance could differ materially, and undue reliance should not be placed on such statements. Skylight Health does not undertake to update any forward-looking statements except as required. All currencies discussed on this call will be in Canadian dollars unless otherwise stated. This conference call is being recorded today, Thursday, March 31st, 2022 at 8 a.m. and will be posted to the Skylight Health's website within 24 hours after the conclusion of the call. I would now like to turn the meeting over to Skylight Health's Chief Executive Officer, Mr. Pradyum Shaker. Please go ahead.

Thank you, Ariel. And a good morning to everyone and thank you for joining us for our fourth quarter and full year conference call for the period ending December 31st, 2021. With me this morning is our Chief Financial Officer, Andrew Olinsky, who will provide you with a more detailed overview of our financial performance in a moment. Skylight Health is a primary care focused organization that is committed to changing how healthcare works in the US. We operate a multi-state primary healthcare network comprised of practices providing a range of services from primary care, subspecialty, allied health, and laboratory diagnostic testing. Our business model is focused on solving two major issues in U.S. healthcare. First, providing a white knight solution to small and independent primary care practices looking to consolidate within a highly fragmented market and where providers and practices are eagerly looking for qualified and supportive buyers. Through a national platform, we aim to bring scale, efficiency, and improved revenues to these practices. Second, we aim to realign the reimbursement model with these practices to outcome-based care, or more commonly known as value-based care contracting. Our focus with specific patient populations today, such as Medicare, is to shift from a traditional fee-for-service only model that typically generates on average between $100 to $200 per visit or $200 to $400 per year to a value-based care model where some full-risk total cost of care programs can remunerate the provider group over $10,000 by year paid by the payers, not the patients. This enables the practice to receive the full healthcare dollar, putting the patient first and allocating expenses accordingly. Value-based care models are designed to manage the growing cost of care while improving on patient health outcomes. 2021 was definitely a busy year for us. Some things we're definitely really happy about and some things that we're definitely cognizant about moving into 2022. But the things that we're pleased and the things that we're able to bring to the organization was a turnaround in the Skylight Health group, positioning ourselves as a player within the primary care market in the US healthcare. We're happy about the progress we were able to bring between 2019 to 2020 to 2021. We made significant acquisitions during the course of this time that allowed us to recognize strong and rapid growth, the ability to recognize leaders within these organizations that have been able to come onto Skylight Health, and we have been able to leverage from their knowledge and expertise and will be instrumental in allowing us to scale as we move forward. It's allowed us to expand into new markets, markets where we believe we have density of growth, density of acquisitions, and density of the ability to bring value-based care to patients. We also saw a shift into two major exchanges, allowing Skylight to really mature into an organization, but also have access to investors and an investment community that can benefit Skylight Health plan into the value-based care space. we saw strong leaders join the organization. From the board, with the appointment of Grace Mellis and Patrick McNamee, and within the organization, from leadership, down to management level, down to staff, we're really happy and pleased about the growth that we've been able to bring, allowing us to now have the infrastructure to benefit from scale and growth. Some of the things that we are cognizant about, as we as an organization look at 2021, we're cognizant about the cost and time that it takes to make change and turnaround happen. While change takes time and does have an expense to it, we are aware that these are necessary investments that are required to build the infrastructure to manage such rapid growth. Furthermore, to lay the infrastructure for the future we're looking to build. And I'll be coming back to talk about these initiatives in a few moments. So with that, I'll turn the call over to Andrew Olinsky, who will go over our financial results in more detail.

Thank you, Brad.